Ocular angiogenesis; a new in vivo experimental model.
Grignolo
F M
FM
Eye Clinic I, University of Turin.
Emanuelli
L
L
Eandi
C M
CM
Brogliatti
B
B
D000368:Aged; D000818:Animals; D001082:Aqueous Humor / Q000502:physiology*; D001672:Biocompatible Materials; D003094:Collagen; D003930:Diabetic Retinopathy / Q000150:complications / Q000378:metabolism; D004195:Disease Models, Animal; D004338:Drug Combinations; D016228:Endothelial Growth Factors / Q000378:metabolism; D005109:Extracellular Matrix; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect; D015355:Glaucoma, Neovascular / Q000150:complications / Q000378:metabolism; D006801:Humans; D007797:Laminin; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D011509:Proteoglycans; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D001672:Biocompatible Materials; D004338:Drug Combinations; D016228:Endothelial Growth Factors; D007797:Laminin; D008222:Lymphokines; D011509:Proteoglycans; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; C059485:matrigel; D003094:Collagen